Infectious Risk after Allogeneic Hematopoietic Cell Transplantation Complicated by Acute Graft-versus-Host Disease
Authors:
Open Access
- 1 March 2017
- journal article
- research article
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 23 (3) , 522-528
Abstract
No abstract availableKeywords
Funding Information
- National Cancer Institute (P01CA039542)
- National Heart, Lung, and Blood Institute (T32HL007622-27)
This publication has 33 references indexed in Scilit:
- Update of hematopoietic cell transplantation for sickle cell diseaseCurrent Opinion in Hematology, 2015
- Pretransplant comorbidities predict severity of acute graft-versus-host disease and subsequent mortalityBlood, 2014
- Use of antibacterial prophylaxis in patients with chemotherapy-induced neutropeniaCurrent Opinion in Hematology, 2012
- Graft-vs-Host Disease following Allogeneic Hematopoietic Cell TransplantationCancer Control, 2011
- Cytopenias after day 28 in allogeneic hematopoietic cell transplantation: impact of recipient/donor factors, transplant conditions and myelotoxic drugsHaematologica, 2011
- Antimicrobial prophylaxis regimens following transplantationCurrent Opinion in Infectious Diseases, 2011
- Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global PerspectiveTransplantation and Cellular Therapy, 2009
- Invasive Aspergillosis following Hematopoietic Cell Transplantation: Outcomes and Prognostic Factors Associated with MortalityClinical Infectious Diseases, 2007
- Practice parameter for the diagnosis and management of primary immunodeficiencyAnnals of Allergy, Asthma & Immunology, 2005
- The Current Status of Hematopoietic Cell TransplantationAnnual Review of Medicine, 2003